Former FDA commissioner suggests 'dual strategy' to expedite COVID-19 vaccinations

While experts are urging patience with the slower-than-expected United States vaccine rollout, former Food and Drug Administration Commissioner Scott Gottlieb on Sunday suggested a logistical fix that could help speed things up.
Appearing on CBS News' Face the Nation, Gottlieb told host Margaret Brennan he thinks the U.S. should allow public health departments to focus on getting the vaccine to hard-to-reach, vulnerable communities while simultaneously making the shots available to the wider population — with priority based on age — through retail pharmacies like Walgreens and CVS. "You're not gonna see the long lines," he said. "They're gonna have a scheduling system in place, and it's gonna be a more orderly distribution."
Meanwhile, Dr. Moncef Slaoui, Operation Warp Speed's chief science adviser, also appeared on Face the Nation, telling Brennan he isn't keen on following the United Kingdom's lead by spreading out the time between the first and second doses of the vaccines as a method for getting more people inoculated at a faster rate, since evidence is lacking. But he did say that "we know" Moderna's vaccine induces an "identical immune response" when given at half the dosage that is currently being administered. If that change is eventually allowed by the FDA, two shots would still be required, but it would still save enough of the vaccine to expedite the process. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published